In the early stages of CKD, a “trade-off” mechanism maintains plasma phosphate concentrations within physiological limits by an increase in the production of parathormone (PTH) and fibroblast growth factor 23 (FGF 23), increasing renal phosphate clearance [11]. This evidence concerns the gene PTH and chronic kidney disease.